Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 5134.07 | 578 / 578 | 96% | 25.87 | 1113 / 1155 |
esophagus | 98% | 1181.22 | 1416 / 1445 | 97% | 29.55 | 177 / 183 |
intestine | 97% | 1193.06 | 941 / 966 | 96% | 21.15 | 507 / 527 |
brain | 97% | 1047.61 | 2567 / 2642 | 95% | 14.92 | 669 / 705 |
thymus | 100% | 1718.44 | 650 / 653 | 92% | 15.76 | 554 / 605 |
uterus | 99% | 948.61 | 168 / 170 | 90% | 21.27 | 413 / 459 |
breast | 100% | 1154.68 | 457 / 459 | 87% | 13.86 | 974 / 1118 |
kidney | 97% | 975.33 | 86 / 89 | 84% | 21.38 | 757 / 901 |
adrenal gland | 100% | 2030.40 | 258 / 258 | 77% | 21.19 | 176 / 230 |
ovary | 72% | 530.17 | 130 / 180 | 98% | 18.97 | 421 / 430 |
bladder | 86% | 590.43 | 18 / 21 | 81% | 20.28 | 407 / 504 |
stomach | 65% | 624.30 | 235 / 359 | 96% | 25.71 | 274 / 286 |
prostate | 100% | 1136.25 | 244 / 245 | 48% | 4.73 | 243 / 502 |
liver | 81% | 798.91 | 183 / 226 | 60% | 7.78 | 242 / 406 |
skin | 58% | 357.97 | 1045 / 1809 | 77% | 30.79 | 365 / 472 |
pancreas | 23% | 127.33 | 75 / 328 | 94% | 24.14 | 168 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 99.35 | 29 / 29 |
spleen | 100% | 4835.63 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.91 | 1 / 1 |
adipose | 99% | 1632.36 | 1194 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5945.23 | 915 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 28.85 | 42 / 45 |
heart | 89% | 969.09 | 770 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 30.00 | 71 / 80 |
blood vessel | 87% | 921.66 | 1163 / 1335 | 0% | 0 | 0 / 0 |
muscle | 14% | 73.04 | 112 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0006955 | Biological process | immune response |
GO_0042270 | Biological process | protection from natural killer cell mediated cytotoxicity |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0002448 | Biological process | mast cell mediated immunity |
GO_0005615 | Cellular component | extracellular space |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043027 | Molecular function | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SERPINB9 |
Protein name | Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9) |
Synonyms | PI9 |
Description | FUNCTION: Granzyme B inhibitor. |
Accessions | ENST00000380698.5 P50453 |